name: Inferolateral border of posterior part of right cerebral hemisphere


name: Superomedial border of left cerebral hemisphere


name: Cluster of differentiation transmembrane protein


name: Inferolateral border of posterior part of cerebral hemisphere


name: BELT,SUPPORT 4IN X-LARGE NU-HOPE #2668-A


name: BELT,SUPPORT 4IN X-LARGE NU-HOPE #2668-BP


name: BELT,SUPPORT 4IN X-LARGE NU-HOPE #2668-C


name: BELT,SUPPORT 5IN XX-LARGE NU-HOPE #6424-A


name: BELT,SUPPORT 6IN X-LARGE NU-HOPE #6433-A


name: BELT,SUPPORT 6IN X-LARGE NU-HOPE #6433-B


name: BELT,SUPPORT 6IN X-LARGE NU-HOPE #6433-C


name: BELT,SUPPORT 6IN X-LARGE NU-HOPE #6433-SP


name: CATHETER,EXTERNAL CONVEEN #5140H X-LARGE


name: CATHETER,EXTERNAL GOLDEN DRAIN LG #A1000


name: DRESSING,COVADERM PLUS 2.5IN X 2.5IN DEROYAL #46-411


name: DRESSING,COVADERM PLUS 2IN X 2IN DEROYAL #46-400


name: DRESSING,COVADERM PLUS 6IN X 8IN DEROYAL #46-403


name: HOSE ANTI-EMBOLISM KNEE LEN XX-LRG-SHORT


name: IV SET PRIMARY,NON-VENTED HOSPIRA #11545-58


name: POISE PAD,MAXIMUM ABSORBENCY EXTRA COVERAGE


name: TUBING,EXTENSION 18IN W/CONNECTOR MENTOR #7082


name: {10 (dirithromycin 250 MG Delayed Release Oral Tablet) } Pack


name: Lozenge, Multi Ingredient Oromucosal Lozenge/Troche


name: Duane Reade Super Thin Sterile Tip Lancet


name: Vagisil Intimate Lubricant, topical lotion


name: BD Vacutainer Blood Collection plus Access De


name: BD Vacutainer Eclipse Blood Collection plus A


name: antihemophilic factor recombinant albumin-free intravenous kit


name: infusion set for insulin pump MISCELL INFUSION SETS-PARAPHERNALIA


name: RID Home Lice Control Spray for Surfaces


name: RID Home Lice Control Spray for Surfaces, 0.5% topical spray


name: desonide topical 0.05% with emollients topical kit


name: OCTYL METHOXYCINNAMATE/OCTYL SALICYLATE/OXYBENZONE SPF-15 LOTION


name: {1 (85 ML) (sulfacetamide sodium 100 MG/ML Topical Lotion) / 1 (120 ML) (urea 100 MG/ML Medicated Shampoo) } Pack


name: {1 (200 ML Citric Acid 123 MG/ML / magnesium carbonate 816 MEQ/ML / potassium citrate 0.056 MEQ/ML Oral Solution) / 1 (Bisacodyl 10 MG Rectal Suppository) / 4 (Bisacodyl 5 MG Enteric Coated Tablet) } Pack [LoSo Prep Bowel Cleansing System]


name: {1 (1.2 ML) (interferon alfa-2b 15000000 UNT/ML Injectable Solution [Intron A]) / 84 (ribavirin 200 MG Oral Capsule [Rebetol]) } Pack [Rebetron Combination Package for Patients > = 75 KG, Intron A 15,000,000 UNT/ML Multi-Dose Pen / 84 Rebetol Capsules]


name: {1 (1.2 ML) (interferon alfa-2b 15000000 UNT/ML Injectable Solution [Intron A]) / 42 (ribavirin 200 MG Oral Capsule [Rebetol]) } Pack [Rebetron Combination Package for Rebetol Dose Reduction, Intron A 15,000,000 UNT/ML Multi-Dose Pen / 42 Rebetol Capsules]


name: hydrocortisone-lidocaine topical w psyllium


name: CATHETER FOLEY 2-WAY 10FR 3CC M#DYND11710


name: CATHETER FOLEY 2-WAY 8FR 3CC M#DYND11708


name: CATHETER,URETHRAL COUDE 12FR BARD #010112


name: CATHETER,URETHRAL COUDE 14FR BARD #010114


name: CATHETER,URETHRAL COUDE 16FR BARD #010116


name: HEAT & MOISTURE EXCHANGER,THERMOVENT #570015


name: STATLOCK PICC PLUS,PIC0220 ANCHORING DEVICE


name: STATLOCK PICC PLUS,PIC0222 ANCHORING DEVICE


name: STATLOCK PICC PLUS,VPPCSP ANCHORING DEVICE


name: STATLOCK PICC PLUS,VPPDFP ANCHORING DEVICE


name: TRACH TUBE,SZ 10 CUFFED FLEX DIC #505100


name: TRACH TUBE,SZ 10 CUFFLESS FLEX DIC #504100


name: TRACH TUBE,SZ 6 CUFFLESS FLEX DIC #504060


name: TRACH TUBE,SZ 7 CUFFLESS FLEX DIC #504070


name: TRACH TUBE,SZ 8 CUFFLESS FLEX DIC #504080


name: TRACH TUBE,SZ 9 CUFFLESS FLEX DIC #504090


name: {30 (anastrozole 1 MG Oral Tablet) } Pack


name: {30 (anastrozole 1 MG Oral Tablet [Arimidex]) } Pack [Arimidex]


name: {1 (297 ML) (benzoyl peroxide 40 MG/ML Medicated Liquid Soap [Zaclir]) / 1 (113 ML) (sodium hyaluronate 0.002 MG/MG Topical Gel [Hylira]) } Pack [Zacare 4/0.2]


name: {1 (297 ML) (benzoyl peroxide 80 MG/ML Medicated Liquid Soap [Zaclir]) / 1 (113 ML) (sodium hyaluronate 0.002 MG/MG Topical Gel [Hylira]) } Pack [Zacare 8/0.2]


name: chromium picolinate 12 % MISCELL POWDER (GRAM)


name: nutritional therapy, glutaric aciduria type 1 15.1 gram-500 kcal/100 gram ORAL POWDER (GRAM)


name: nut.tx. metabolic disorder,soy 0.067 gram-1.30 kcal/mL ORAL LIQUID (ML)


name: nut.tx. metabolic disorder,soy 400 kcal/100 gram ORAL POWDER (GRAM)


name: nutritional therapy, impaired renal function,lactose-reduced 0.04 gram-1.8 kcal/mL ORAL LIQUID (ML)


name: nutritional therapy, impaired renal function,lactose-reduced 0.08 gram-1.8 kcal/mL ORAL LIQUID (ML)


name: nutritional therapy for isovaleric acidemia with iron 16.2 gram-500 kcal/100 gram ORAL POWDER (GRAM)


name: nutritional therapy, metabolic disorder, methionine-free 60 gram-302 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: urostomy pouch 2 1/2" (11") MISCELL EACH


name: Restore Plus Conformable/Tapered Edge Dressin


name: New Image Cut-to-Fit Convex Flextend Skin Bar


name: permethrin/piperonyl butoxide/pyrethr topical topical kit


name: Preparation H Medicated Wipes Refill Pack


name: benzoyl peroxide-sodium hyaluronate topical


name: {1 (225 ML) (ammonium lactate 120 MG/ML Topical Lotion [Lac-Hydrin]) / 1 (50 ML) (halobetasol propionate 0.0005 MG/MG Topical Ointment [Ultravate]) } Pack [Ultravate Pac]


name: hemodialysis solution no. 65 without dextrose


name: hemodialysis solution no. 66 without dextrose


name: hemodialysis solution no. 67 without dextrose


name: hemodialysis solution no. 68 without dextrose


name: hydrocolloid dressing 7 1/2" X 4 1/2" TOPICAL BANDAGE


name: nutritional therapy, compromised immune system, regular 0.06 gram-1 kcal/mL ORAL LIQUID (ML)


name: nutritional therapy, compromised immune system, regular 0.08 gram-1.4 kcal/mL ORAL LIQUID (ML)


name: vehicle base no.18 58 %-41 %-1 % MISCELL WAX (GRAM)


name: BANDAGE,GAUZE,STRETCH 2IN X 65IN NONSTERILE


name: BANDAGE,GAUZE,STRETCH 3IN X 75IN NONSTERILE


name: BANDAGE,GAUZE,STRETCH 3IN X 75IN STERILE


name: BANDAGE,GAUZE,STRETCH 4IN X 75IN NONSTERILE


name: BANDAGE,GAUZE,STRETCH 4IN X 75IN STERILE


name: BANDAGE,GAUZE,STRETCH 6IN X 85IN NONSTERILE


name: BANDAGE,GAUZE,STRETCH 6IN X 85IN STERILE


name: BANDAGE,KERLIX 2.25IN X 3YD STERILE KEN#6720


name: BELT,SUPPORT 7IN MEDIUM NU-HOPE #6441-SP


name: CARTRIDGE,ANIMAS IR 2ML 1200 #100-124-01


name: CARTRIDGE,ANIMAS IR 3ML 1000 #100-052-01


name: CATHERIZATION SET,INTERMITTENT,14FR APOGEE H#B14F


name: {1 (benzoyl peroxide 50 MG/ML Medicated Pad) / 1 (salicylic acid 20 MG/ML Medicated Pad) } Pack [Cleanse and Treat]


name: Accu-Chek Comfort Curve Test Strips Medicaid


name: nutritional therapy, metabolic disorder, methionine-free 0.115 gram-0.71 kcal/mL ORAL SUSPENSION, ORAL (FINAL DOSE FORM)


name: nut.supplement,special formula,lactose-free with iron/fos 0.08 gram-2 kcal/mL ORAL LIQUID (ML)


name: nut. supp.,special formulas, lac-free,with iron


name: Medical Information Identification Tag MISCELL EACH


name: hydrocolloid dressing 7 1/2" X 7 4/5" TOPICAL BANDAGE


name: nutritional therapy for phenylketonuria(PKU) with iron no.35 10 gram-156 kcal/40 gram ORAL POWDER IN PACKET (EA)


name: nut. tx., phenylketonuria (PKU) with iron, no.35


name: human prothrombin complex conc. (PCC) comb.1


name: nutritional therapy for phenylketonuria(PKU) with iron no.35 25 gram-390 kcal/100 gram ORAL POWDER (GRAM)


name: {21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Ocella 28 Day]


name: CATHETER FOLEY 6FR 3CC MEDLINE #DYND11706


name: CATHETER,EXTERNAL GOLDEN DRAIN LG #A1100M


name: Acrylate Terpolymer/Hexamethyldisiloxane Topical application Spray [CAVILON NO STING BARRIER FILM]


name: DRESSING,SOLOSITE GEL CONFORMABLE 2IN X 2IN


name: DRESSING,SOLOSITE GEL CONFORMABLE 4IN X 4IN


name: HEAT & MOISTURE EXCHANGER,HUMID-VENT #14412


name: HEAT & MOISTURE EXCHANGER,HUMID-VENT #17732


name: SUCTION TUBE ATTACHMENT DEVICE MEDLINE #DYND50142


name: SUCTION TUBE ATTACHMENT DEVICE MEDLINE #DYND52132


name: TRACHEAL SUCTION SET 12FR SMITHS #6101-12


name: TRACHEAL SUCTION SET 14FR SMITHS #6101-14


name: WINGS CONTOURED INCONTINENT BRIEF X-LARGE


name: {10 (12 HR chlorpheniramine maleate 4 MG / methscopolamine nitrate 2.5 MG Extended Release Oral Tablet) / 10 (12 HR chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG Extended Release Oral Tablet) } Pack [RespiVent DF Dosepack 10]


name: Authorization for Release of Confidential Health Information Indicator


name: Original Unit or Value of Reported Test Result Indicator


name: Injectable Lyophilized Powder Dosage Form


name: Institutional Review Board Approval Date


name: International Classification of Diseases, Ninth Revision


name: International Network of Food Data Systems


name: International Staging System for Myeloma


name: Intracellular Fluorescence Polarization Analysis


name: 12 Lead Placement Standard And CC5-CM5-CH5


name: 12 Lead Placement Standard And CC5-CM5-ML


name: 12 Lead Placement Standard Extended Left


name: 12 Lead Placement Standard Extended Right


name: 50 Percent Cell Culture Infective Dose per Dose


name: 50 Percent Embryo Infective Dose per Dose


name: 50 Percent Tissue Culture Infective Dose per Dose


name: Investigational Device Exemption 520(G) (CDRH)


name: Investigational New Drug Exemption (CBER)


name: Investigational New Drug Exemption (CDER)


name: Iodine I 124-Iodo-Azomycin Galactopyranoside


name: L-Arginine/American Ginseng/Korean Ginseng/Ginkgo biloba-Based Supplement


name: Lead Placement EASI Dower Transformation


name: Lead Placement Standard Intercostal Space Higher


name: Linear Regression Body Surface Area Formula for Infants and Children


name: Log10 50 Percent Cell Culture Infective Dose


name: Log10 50 Percent Cell Culture Infective Dose per Dose


name: Log10 50 Percent Embryo Infective Dose per Dose


name: Log10 50 Percent Tissue Culture Infective Dose


name: Log10 50 Percent Tissue Culture Infective Dose per Dose


name: Log10 Enzyme-Linked Immunosorbent Assay Unit


name: Log10 Enzyme-Linked Immunosorbent Assay Unit per Dose


name: Log10 Fluorescent Assay Infectious Dose 50 Percent


name: Log10 Fluorescent Assay Infectious Dose 50 Percent per Dose


name: Accessory for Intravenous Admixture Preparation


name: Alternative Hematopoietic Cell Transplantation


name: Anti-Xa Activity International Unit per Milliliter


name: Application to Market New Drug, Biologic, or Antibiotic for Human Use


name: Approved Protocol - clinical study status


name: Authorization for Release of Confidential Health Information


name: Autologous Dendritic Cell-Adenovirus CCL21 Vaccine


name: Autologous Dendritic Cell-Tumor Fusion Vaccine


name: Autologous Follicular Lymphoma-Derived Idiotype Vaccine


name: BCR-ABL p210-b3a2 Breakpoint-derived Pentapeptide Vaccine


name: Modified Vaccinia Ankara (Bavarian Nordic)-HER2 Vaccine


name: Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine


name: Billion Colony Forming Units per Milliliter


name: Marketed as Authorized Generic under New Drug Application


name: Marketed as Unapproved Homeopathic Product


name: Marketed under Abbreviated New Animal Drug Application


name: Marketed under Abbreviated New Drug Application


name: Marketed under Biologic License Application


name: Marketed under Conditional Approval of New Animal Drug Application


name: Marketed under New Animal Drug Application


name: Marketed under Over-the-Counter Drug Product Final Monograph


name: Marketed under Over-the-Counter Drug Product Not Final Monograph


name: Million Colony Forming Units per Milliliter


name: Mitogen-Activated Protein Kinase Kinase Inhibitor


name: Receptor Tyrosine Kinase Inhibitor R1530


name: British Thermal Unit 39 Degrees Fahrenheit


name: British Thermal Unit 59 Degrees Fahrenheit


name: British Thermal Unit 60 Degrees Fahrenheit


name: British Thermal Unit International Table


name: Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine


name: Oral Reconstituted Suspension Dosage Form


name: Original Unit or Value of Reported Test Result


name: Osmotic Laser Drilled Tablet Dosage Form


name: PVA Microporous Hydrospheres/Doxorubicin Hydrochloride


name: Participating Clinical Study Organization


name: Performed Procedure Step SOP Instance UID


name: Permanent Intervention Discontinuation, No Subject Follow Up


name: Permanent Intervention Discontinuation, Subject Continues Follow Up


name: Planned Duration of Study Subject Participation


name: Planned Intervention Duration for Study Subject


name: Plant-Derived Hematopoiesis Enhancer PG2


name: Plaque Forming Unit Equivalent 1000 Mouse LD50


name: Capsule 12 Hour Sustained Release Dosage Form


name: Capsule 24 Hour Sustained Release Dosage Form


name: Cause or Rationale for Missed Study Activity


name: Certified Clinical Research Professional


name: Certified Medical Assistant (occupation)


name: Certified Nurse Practitioner (occupation)


name: Chemical_Formula - NCI Thesaurus Property


name: Regimen Used to Treat Gestational Trophoblastic Tumor


name: Powder Like Non-Effervescent Granule Dosage Form


name: Clinical Study Site Pending IRB Approval


name: Clinical Study by Organizational Parameters


name: Clinical Study by Targeted Disease or Condition


name: Symphytum officinale / comfrey leaf / comfrey root preparation


name: Clinical Study Activity Relationship Comment


name: Compressed Sugar Coated Caplet Dosage Form


name: Condition-Specific Capitation Payment Method


name: Beam - rays of radiation or stream of particles


name: Study Administrative Activity Variance Reason


name: Recombinant Adenovirus-Interferon SCH 721015


name: Regulatory Application Unique Identifier


name: Regulatory Submission Receipt Date and Time


name: Dendritic Cell-Idiotype-Keyhole Limpet Hemocyanin Vaccine


name: Scheduled Study Activity Cause or Rational


name: Simple Random Sampling without Replacement


name: Site Participation in Clinical Study Cancelled


name: Intravenous Piggyback Solution Dosage Form


name: Dubois and Dubois Body Surface Area Formula


name: Allogeneic B7.1/HLA-A1 Transfected Tumor Cell Vaccine


name: End Date of Clinical Study Site Participation in Study


name: Enzyme-Linked Immunosorbent Assay Unit per Dose


name: Enzyme-Linked Immunosorbent Assay Unit per Milliliter


name: Federal Information Processing Standards


name: Standardized Freeze-Dried Table Grape Powder


name: Scheduled Study Activity for Study Subject


name: Structured Product Labeling Marketing Category


name: Subject Completed Participation in Study


name: Subject's Signature on Informed Consent Form


name: Clinical Trial Subject Unique Identifier


name: Suspension 12 Hour Sustained Release Dosage Form


name: Suspension for Reconstitution Dosage Form


name: Sustained Release Oral Liquid Dosage Form


name: Sustained Release Parenteral Dosage Form


name: Sustained Release Pellet Capsule Dosage Form


name: Synthetic Brain Tumor Peptides-Pulsed Autologous Dendritic Cell Vaccine


name: Tablet 12 Hour Sustained Release Dosage Form


name: Tablet 24 Hour Sustained Release Dosage Form


name: Fluorescent Assay Infectious Dose 50 Percent


name: Fluorescent Assay Infectious Dose 50 Percent per Dose


name: Food, Drugs, and Medical Devices Regulatory Document


name: GD2 Lactone/GD3 Lactone-KLH Conjugate Bivalent Vaccine


name: Gehan and George Body Surface Area Formula


name: Thousand Colony Forming Units per Milliliter


name: Tolerance Induction Pre-Solid Organ Transplant


name: Tositumomab and Iodine I 131 Tositumomab Therapy


name: Clinical Study Activity Relationship Type


name: Clinical Study Document Relationship Type


name: AML mRNA Positive Lysate Loaded Autologous Dendritic Cell Vaccine


name: Glioma-Associated Antigen Peptide-Pulsed Autologous Dendritic Cell Vaccine


name: HLA-A*2402-Restricted URLC10-TTK-VEGFR1-VEGFR2 Multipeptide Vaccine


name: High-Intensity Focused Ultrasound Ablation


name: Hoechst Adverse Reaction Terminology System


name: Human Papilloma Virus L1 Virus-Like Particle V504 Vaccine


name: Umbilical Cord Blood-Derived Lymphocyte Therapy


name: Unapproved Drug Other Marketing Category


name: Unit of Relative Amount of Substance Content


name: Unit of Volumetric Electrical Charge Density


name: Waiver of Authorization for Release of Confidential Health Information


name: Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12


name: APE/Gestational Trophoblastic Tumor Regimen


name: Colloidal Solution or Suspension Dosage Form


name: orthodontics fitting and adjustment (treatment)


name: rationale for level of preventive care documented


name: Insertion of intra-aneurysm sac pressure monitoring device (intraoperative)


name: Insertion of pressure sensor during endovascular repair of abdominal or thoracic aortic aneurysm(s)


name: Intravascular pressure measurement of coronary arteries


name: Intravascular pressure measurement of intrathoracic arteries


name: Intravascular pressure measurement of peripheral arteries


name: Intravascular pressure measurement, other specified and unspecified vessels


name: OTHER MISCELLANEOUS DIAGNOSTIC AND THERAPEUTIC PROCEDURES


name: Laparoscopic repair of direct inguinal hernia with graft or prosthesis


name: Laparoscopic repair of direct and indirect inguinal hernia with graft or prosthesis


name: Laparoscopic repair of indirect inguinal hernia with graft or prosthesis


name: Laparoscopic repair of inguinal hernia with graft or prosthesis, not otherwise specified


name: Laparoscopic repair of bilateral direct inguinal hernias with graft or prosthesis


name: Laparoscopic repair of bilateral indirect inguinal hernias with graft or prosthesis


name: Laparoscopic repair of bilateral, one direct and one indirect, inguinal hernias with graft or prosthesis


name: Laparoscopic bilateral repair of inguinal hernia with graft or prosthesis, not otherwise specified


name: Laparoscopic multiple segmental resection of large intestine


name: Laparoscopic resection of transverse colon


name: Other laparoscopic partial excision of large intestine


name: Laparoscopic partial excision of large intestine


name: Thoracoscopic robotic assisted procedure


name: Other and unspecified robotic assisted procedure


name: Robotic procedure with computer assistance


name: Temporary percutaneous dilatational tracheostomy


name: Permanent percutaneous dilatational tracheostomy


name: Endoscopic pulmonary airway flow measurement


name: Other endoscopic procedures in bronchus or lung


name: Excision, destruction, or exclusion of left atrial appendage (LAA)


name: Implantation of total internal biventricular heart replacement system


name: Removal of internal biventricular heart replacement system


name: Implantation or insertion of biventricular external heart assist system


name: Temporary cardiac support for both left and right ventricles, inserted in the same operative episode


name: Insertion of temporary non-implantable extracorporeal circulatory assist device


name: Removal of external heart assist system(s) or device(s)


name: Explantation of external device(s) providing left and right ventricular support


name: Explantation of single external device and cannulae


name: Implant of single ventricular (extracorporeal) external heart assist system


name: Insertion of one device into one ventricle


name: Open and other multiple segmental resection of large intestine


name: Open and other resection of transverse colon


name: Other and unspecified partial excision of large intestine


name: Open and other partial excision of large intestine


name: Laparoscopic total intra-abdominal colectomy


name: Other and unspecified total intra-abdominal colectomy


name: Percurtaneous (endoscopic) feeding enterostomy


name: Pull-through resection of rectum, not otherwise specified


name: Laparoscopic pull-through resection of rectum


name: Abdominoperineal resection of the rectum, not otherwise specified


name: Laparoscopic abdominoperineal resection of the rectum


name: Open abdominoperineal resection of the rectum


name: Other abdominoperineal resection of the rectum


name: Other and open repair of direct inguinal hernia


name: Other and open repair of indirect inguinal hernia


name: Other and open repair of direct inguinal hernia with graft or prosthesis


name: Other and open repair of indirect inguinal hernia with graft or prosthesis


name: Other unilateral repair of inguinal hernia


name: Other and open bilateral repair of direct inguinal hernia


name: Other and open bilateral repair of indirect inguinal hernia


name: Other and open bilateral repair of inguinal hernia, one direct and one indirect


name: Other and open bilateral repair of direct inguinal hernia with graft or prosthesis


name: Other and open bilateral repair of indirect inguinal hernia with graft or prosthesis


name: Other and open bilateral repair of inguinal hernia, one direct and one indirect, with graft or prosthesis


name: Other bilateral repair of inguinal hernia


name: Other and open repair of umbilical hernia with graft or prosthesis


name: Laparoscopic repair of umbilical hernia with graft or prosthesis


name: Other laparoscopic umbilical herniorrhaphy


name: Other open incisional hernia repair with graft or prosthesis


name: Laparoscopic incisional hernia repair with graft or prosthesis


name: Other laparoscopic repair of other hernia of anterior abdominal wall with graft or prosthesis


name: Other and open repair of other hernia of anterior abdominal wall with graft or prosthesis


name: Laparoscopic repair of diaphragmatic hernia, abdominal approach


name: Other and open repair of diaphragmatic hernia, abdominal approach


name: Repair of diaphragmatic hernia, abdominal approach, not otherwise specified


name: Laparoscopic repair of diaphragmatic hernia, with thoracic approach


name: Other and open repair of diaphragmatic hernia, with thoracic approach


name: Repair of the anulus fibrosus with graft or prosthesis


name: Other and unspecified repair of the anulus fibrosus


name: Microsurgical suture repair without fascial autograft


name: Percutaneous repair of the anulus fibrosus


name: Excision, destruction and other repair of intervertebral disc


name: Insertion of inflatable balloon, bone tamp, or other device displacing bone to create a space prior to the injection of bone void filler or other substance


name: Total reconstruction of breast, not otherwise specified


name: Transverse rectus abdominis myocutaneous (TRAM) flap, pedicled


name: Transverse rectus abdominis myocutaneous (TRAM) flap, free


name: Deep inferior epigastric artery perforator (DIEP) flap, free


name: Superficial inferior epigastric artery (SIEA) flap, free


name: Gluteal artery perforator (GAP) flap, free


name: BiPAP without (delivery through) endotracheal tube or tracheostomy


name: CPAP without (delivery through) endotrachael tube or tracheostomy


name: Continuous invasive mechanical ventilation of unspecified duration


name: Continuous invasive mechanical ventilation for less than 96 consecutive hours


name: Continuous invasive mechanical ventilation for 96 consecutive hours or more


name: Other continuous invasive mechanical ventilation


name: BiPAP delivered through endotracheal tube or tracheostomy


name: BiPAP delivered through invasive interface


name: CPAP delivered through endotracheal tube or tracheostomy


name: CPAP delivered through invasive interface


name: Mechanical ventilation through invasive interface


name: SUPPLEMENTARY CLASSIFICATION OF FACTORS INFLUENCING HEALTH STATUS AND CONTACT WITH HEALTH SERVICES


name: Dental restoration - filling amalgam (treatment)


name: breakpoint cluster region BCR (lab test)


name: Transmission Electron Microscopy Tomography


name: Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography


name: National Institute of Neurological Disorders and Stroke (U.S.)


name: International Red Cross and Red Crescent Movement


name: orthopedic surgical procedure-external fixation devices


name: aftercare following surgery for neoplasm (treatment)


name: Chemotherapy Gloves, Latex-Free, Xtra-Large


name: LiteAire Collapsible Dual-Valved Chamber


name: codeine / dexchlorpheniramine / phenylephrine


name: dextromethorphan / pseudoephedrine / pyrilamine


name: chlophedianol / guaifenesin / pseudoephedrine


name: nutritional therapy, urea cycle disorder without iron 79 gram-316 kcal/100 gram ORAL POWDER (GRAM)


name: CATHERIZATION SET,FOLEY 18FR BARD #898318


name: CATHETER,INTERMITTENT 14FR RUSCH #220800-14


name: BELT,OSTOMY REGULAR PERMA TYPE #C116R000


name: CATHERIZATION SET,FOLEY 14FR BARD #898314


name: CATHERIZATION SET,FOLEY 16FR BARD #898316


name: DRESSING,ALLEVYN THIN 2IN X 2 3/8IN,U#7576


name: TRACH VALVE HOUSING,ADHESIVE BLOM-SINGER BE6054


name: TRACHEOSTOMY TUBE HOLDER,SHILEY,LATEX FREE


name: INCONT LINER DIGNITY BRIEFMATES SUPER ABSORB


name: LEG BAG COMBINATION PACK H#9348 LATEX FREE


name: SODIUM CHLORIDE MESALT DRESSING 3/4IN X 39IN


name: SUCTION TUBE ATTACHMENT DEVICE SHERWOOD #501031


name: MULTIDEX HYDROPHILIC WOUND DRESSING PWDR,DEROYAL#46-702,PKT,25GM


name: cyclobenzaprine HCl/irritants counter-irritants combo no.2 10 mg MISCELL KIT


name: dimethyl sulfoxide 99 % MISCELL VIAL (ML)


name: hemodialysis solution no.70 without potassium


name: hydrocolloid dressing 17 square inch TOPICAL BANDAGE


name: irritant counter-irritants combination no. 2


name: nutrition tx for urea cycle disorder without iron


name: Dialysis fluid peritoneal + Serum or Plasma


name: Hospitalization leading to pulmonary therapy treatment


name: First & Second trimester integrated maternal screen


name: First trimester maternal screen with nuchal translucency


name: Second trimester penta maternal screen panel


name: Second trimester quad maternal screen panel


name: First & Second trimester integrated maternal screen panel


name: First trimester maternal screen with nuchal translucency panel


name: Estradiol^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Estradiol^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate dehydrogenase 5/Lactate dehydrogenase.total:CFr:Pt:Periton fld:Qn:Electrophoresis


name: Lactate dehydrogenase 5/Lactate dehydrogenase.total:CFr:Pt:Plr fld:Qn:Electrophoresis


name: Lactate dehydrogenase 5/Lactate dehydrogenase.total:CFr:Pt:CSF:Qn:Electrophoresis


name: (Cynodon dactylon+Lolium perenne+Phleum pratense+Poa pratensis+Sorghum halepense+Paspalum notatum) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk


name: Betula verrucosa recombinant (rBet v) 2+4 Ab.IgE:ACnc:Pt:Ser:Qn


name: (Ambrosia elatior+Chenopodium album+Cynodon dactylon+Lolium perenne+Plantago lanceolata+Paspalum notatum) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk


name: (Aspergillus fumigatus+Blatella germanica+Cat dander+Dermatophagoides pteronyssinus) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk


name: (Quercus alba+Ulmus americana+Platanus acerifolia+Salix caprea+Populus deltoides) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk


name: (Citrus sinensis+Citrus limon+Citrus paradisi+Citrus reticulata) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk


name: (Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) Ab.IgE:PrThr:Pt:Ser:Ord:Multidisk


name: Deprecated Psychiatric rehabilitation treatment plan, Past medical history (narrative)


name: Level of function:Cmplx:Pt:Psychiatric rehabilitation treatment plan:Set


name: Deprecated Psychiatric rehabilitation treatment plan, Prior level of function (narrative)


name: Deprecated Psychiatric rehabilitation treatment plan, Current level of function (narrative)


name: Assessment information:Cmplx:Pt:Psychiatric rehabilitation treatment plan:Set


name: Deprecated Psychiatric rehabilitation treatment plan, Assessment indicator


name: Deprecated Psychiatric rehabilitation treatment plan, Functional status (narrative)


name: Deprecated Psychiatric rehabilitation treatment plan, Activities permitted (narrative)


name: Deprecated Psychiatric rehabilitation treatment plan, Mental status (narrative)


name: Deprecated Psychiatric rehabilitation treatment plan, Additional assessment (narrative)


name: Deprecated Psychiatric rehabilitation treatment plan, Treatment encounter (narrative)


name: Deprecated Psychiatric rehabilitation treatment plan, Past treatment attempts (narrative)


name: Progress note+attainment of goals:Cmplx:Pt:Psychiatric rehabilitation treatment plan:Set


name: Deprecated Psychiatric rehabilitation treatment plan Progress note and attainment of goals date range


name: Progress note+attainment of goals date range


name: Deprecated Respiratory therapy treatment plan, Date range (from/through) DateRange


name: Deprecated Respiratory therapy treatment plan, Date range (from/through) of hospitalization leading to treatment


name: Referral information:Cmplx:Pt:Respiratory therapy treatment plan:Set


name: Deprecated Respiratory therapy treatment plan, Referral information (narrative)


name: Deprecated Respiratory therapy treatment plan, Referring person name


name: Deprecated Respiratory therapy treatment plan, Referring person identifier


name: Deprecated Respiratory therapy treatment plan, Date patient referred for treatment


name: Responsible attending physician information:Cmplx:Pt:Respiratory therapy treatment plan:Set


name: Responsible attending physician information


name: Responsible rehabilitation professional information:Cmplx:Pt:Respiratory therapy treatment plan:Set


name: Responsible rehabilitation professional information


name: Deprecated Respiratory therapy treatment plan, Medication rate Flow


name: Deprecated Respiratory therapy treatment plan, Medication timing TQ2


name: Deprecated Respiratory therapy treatment plan, Date range certifying the plan of care DateRange


name: Deprecated Respiratory therapy treatment plan, Physician certification statement (narrative)


name: Deprecated Respiratory therapy treatment plan, Actual start of care date


name: Level of function:Cmplx:Pt:Respiratory therapy treatment plan:Set


name: Deprecated Respiratory therapy treatment plan, Prior level of function (narrative)


name: Deprecated Respiratory therapy treatment plan, Current level of function (narrative)


name: Estradiol^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Estradiol^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Estradiol^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Coagulation thrombin induced.factor substitution^immediately after addition of XXX:Time:Pt:PPP:Qn:Coag


name: Washed packed erythrocytes given:Vol:Pt:^Patient:Qn


name: Direct antiglobulin test.polyspecific reagent:PrThr:Pt:RBCCo:Ord


name: Transfuse platelet concentrate units:Num:Pt:^BPU:Qn


name: Platelet concentrate units given:Num:Pt:^BPU:Qn


name: Varicella zoster virus immune globulin ordered:Num:Pt:^BPU:Qn


name: Malignant cells/100 cells:NFr:Pt:Body fld:Qn:Manual count


name: Coagulation tissue factor induced.factor substitution^after addition of 1:4 normal plasma 1H post incubation separate tubes:Time:Pt:PPP:Qn:Coag


name: Macroblasts/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Complement C1 esterase inhibitor bound Ab:MCnc:Pt:Ser/Plas:Qn


name: Purkinje cell cytoplasmic type Tr Ab:ACnc:Pt:CSF:Qn:IA


name: Home health claims attachment:Find:Pt:^Patient:Doc


name: Home health prior authorization attachment:Find:Pt:^Patient:Doc


name: Home health prior authorization attachment


name: Member ID card copy attachment:Find:Pt:^Patient:Doc


name: Subscriber Information including retroactive and presumptive eligibility attachment:Find:Pt:^Patient:Doc


name: Subscriber Information including retroactive and presumptive eligibility attachment


name: Skilled Nursing Facility record attachment:Find:Pt:^Patient:Doc


name: Skilled Nursing Facility record attachment


name: Dental X-rays and other images (not DICOM) attachment:Find:Pt:^Patient:Doc


name: Dental X-rays and other images (not DICOM) attachment


name: Blood glucose monitors attachment:Find:Pt:^Patient:Doc


name: Continuous positive airway pressure attachment:Find:Pt:^Patient:Doc


name: Continuous positive airway pressure attachment


name: External infusion pump attachment:Find:Pt:^Patient:Doc


name: Orthotics + prosthetics attachment:Find:Pt:^Patient:Doc


name: Power operated vehicles attachment:Find:Pt:^Patient:Doc


name: Repair of durable medical equipment attachment:Find:Pt:^Patient:Doc


name: Repair of durable medical equipment attachment


name: Seat lift mechanism attachment:Find:Pt:^Patient:Doc


name: Speech generating device attachment:Find:Pt:^Patient:Doc


name: Standers + standing frames attachment:Find:Pt:^Patient:Doc


name: Transcutaneous electrical neural stimulation attachment:Find:Pt:^Patient:Doc


name: Transcutaneous electrical neural stimulation attachment


name: Prescription for durable medical equipment attachment:Find:Pt:{Setting}:Doc:{Role}


name: Prescription for durable medical equipment attachment


name: First report of injury attachment:Find:Pt:^Patient:Doc


name: Spermatozoa.slow/100 spermatozoa ^1H post ejaculation:NFr:Pt:Semen:Qn


name: Escherichia coli shiga-like toxin 2:PrThr:Pt:Stool:Ord:IA


name: Deprecated Speech therapy treatment plan, Medication timing TQ2


name: Deprecated Speech therapy treatment plan, Date range certifying the plan of care DateRange


name: Deprecated Speech therapy treatment plan, Physician certification statement (narrative)


name: Deprecated Speech therapy treatment plan, Actual start of care date


name: Deprecated Speech therapy treatment plan, Past medical history (narrative)


name: Level of function:Cmplx:Pt:Speech therapy treatment plan:Set


name: Deprecated Speech therapy treatment plan, Prior level of function (narrative)


name: Deprecated Speech therapy treatment plan, Current level of function (narrative)


name: Deprecated Speech therapy treatment plan, Assessment indicator


name: Deprecated Speech therapy treatment plan, Functional status (narrative)


name: Deprecated Speech therapy treatment plan, Activities permitted (narrative)


name: Deprecated Speech therapy treatment plan, Mental status (narrative)


name: Deprecated Speech therapy treatment plan, Additional assessment (narrative)


name: Deprecated Speech therapy treatment plan, Treatment encounter (narrative)


name: Individual education plan information:Cmplx:Pt:Speech therapy treatment plan:Set


name: Deprecated Speech therapy treatment plan, Individual education plan (narrative)


name: Deprecated Speech therapy treatment plan, Defined school year DateRange


name: Progress note+attainment of goals:Cmplx:Pt:Speech therapy treatment plan:Set


name: Deprecated Speech therapy treatment plan Progress note and attainment of goals date range


name: Assessment information:Cmplx:Pt:Speech therapy treatment plan:Set


name: Deprecated Occupational therapy treatment plan, Date range (from/through) of hospitalization leading to treatment


name: Deprecated Respiratory therapy treatment plan, Past medical history (narrative)


name: Progress note+attainment of goals:Cmplx:Pt:Occupational therapy treatment plan:Set


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Medication identifier


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Medication name Identifier


name: Deprecated Cardiac rehabilitation treatment plan, Medication identifier


name: Deprecated Cardiac rehabilitation treatment plan, Medication name Identifier


name: Deprecated Medical social services treatment plan, Medication identifier


name: Deprecated Medical social services treatment plan, Medication name Identifier


name: Cortisol^6th specimen post XXX challenge:MCnc:Pt:Saliva:Qn


name: Cortisol^7th specimen post XXX challenge:MCnc:Pt:Saliva:Qn


name: Cortisol^5th specimen post XXX challenge:MCnc:Pt:Saliva:Qn


name: Cortisol^4th specimen post XXX challenge:MCnc:Pt:Saliva:Qn


name: Cortisol^3rd specimen post XXX challenge:MCnc:Pt:Saliva:Qn


name: Cortisol^2nd specimen post XXX challenge:MCnc:Pt:Saliva:Qn


name: Cortisol^1st specimen post XXX challenge:MCnc:Pt:Saliva:Qn


name: Estradiol^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Estradiol^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lactate dehydrogenase 1/Lactate dehydrogenase.total:CFr:Pt:Plr fld:Qn:Electrophoresis


name: Lactate dehydrogenase 1/Lactate dehydrogenase.total:CFr:Pt:Periton fld:Qn:Electrophoresis


name: Lactate dehydrogenase 1/Lactate dehydrogenase.total:CFr:Pt:CSF:Qn:Electrophoresis


name: Lactate dehydrogenase 2/Lactate dehydrogenase.total:CFr:Pt:CSF:Qn:Electrophoresis


name: Lactate dehydrogenase 2/Lactate dehydrogenase.total:CFr:Pt:Plr fld:Qn:Electrophoresis


name: Coagulation tissue factor induced^post heparin neutralization:Time:Pt:PPP:Qn:Coag


name: Coagulation surface induced^post heparin neutralization:Time:Pt:PPP:Qn:Coag


name: Osmotic fragility^0.90% sodium chloride:NFr:Pt:RBC:Qn


name: Osmotic fragility^0.90% sodium chloride 24H 37 deg C incubation:NFr:Pt:RBC:Qn


name: Deprecated Physical therapy treatment plan, Medication name Identifier


name: Deprecated Physical therapy treatment plan, Medication identifier


name: Deprecated Psychiatric rehabilitation treatment plan, Medication name Identifier


name: Deprecated Psychiatric rehabilitation treatment plan, Medication identifier


name: Deprecated Respiratory therapy treatment plan, Medication identifier


name: Deprecated Respiratory therapy treatment plan, Medication name Identifier


name: Deprecated Pulmonary therapy treatment plan, Medication identifier


name: Deprecated Pulmonary therapy treatment plan, Medication name Identifier


name: Deprecated Skilled nursing treatment plan, Medication identifier


name: Deprecated Skilled nursing treatment plan, Medication name Identifier


name: Deprecated Speech therapy treatment plan, Medication identifier


name: Deprecated Speech therapy treatment plan, Medication name Identifier


name: Total population of age 40-44Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 45-49Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 50-54Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 55-59Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 60-64Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 65-69Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 70-74Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 75-79Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 80-84Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age GE 85Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Catchment area panel:-:Pt:{Nursing unit}^Population:-:NMMDS


name: Neighborhood catchment area:NFr:Pt:{Nursing unit}^Population:Qn:Estimated


name: City or town catchment area:NFr:Pt:{Nursing unit}^Population:Qn:Estimated


name: District catchment area:NFr:Pt:{Nursing unit}^Population:Qn:Estimated


name: County catchment area:NFr:Pt:{Nursing unit}^Population:Qn:Estimated


name: Parish catchment area:NFr:Pt:{Nursing unit}^Population:Qn:Estimated


name: State catchment area:NFr:Pt:{Nursing unit}^Population:Qn:Estimated


name: Region catchment area:NFr:Pt:{Nursing unit}^Population:Qn:Estimated


name: Nation catchment area:NFr:Pt:{Nursing unit}^Population:Qn:Estimated


name: Lactate dehydrogenase 2/Lactate dehydrogenase.total:CFr:Pt:Periton fld:Qn:Electrophoresis


name: Lactate dehydrogenase 3/Lactate dehydrogenase.total:CFr:Pt:Plr fld:Qn:Electrophoresis


name: Lactate dehydrogenase 3/Lactate dehydrogenase.total:CFr:Pt:Periton fld:Qn:Electrophoresis


name: Lactate dehydrogenase 3/Lactate dehydrogenase.total:CFr:Pt:CSF:Qn:Electrophoresis


name: Lactate dehydrogenase 4/Lactate dehydrogenase.total:CFr:Pt:Periton fld:Qn:Electrophoresis


name: Lactate dehydrogenase 4/Lactate dehydrogenase.total:CFr:Pt:Plr fld:Qn:Electrophoresis


name: Lactate dehydrogenase 4/Lactate dehydrogenase.total:CFr:Pt:CSF:Qn:Electrophoresis


name: Mouse epithelium+Serum proteins+Urine proteins Ab.IgE.RAST class


name: Trichosporon pullulans Ab.IgE.RAST class


name: Normoblasts/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Macrophages/100 leukocytes:NFr:Pt:Bone mar:Qn:Manual count


name: Other cells/100 cells:NFr:Pt:Bone mar:Qn


name: Other cells/100 leukocytes:NFr:Pt:Bld:Qn:Manual count


name: Glucose^1H post 75 g glucose PO:SCnc:Pt:Ser/Plas:Qn


name: Xylose^3H post dose xylose PO:SCnc:Pt:Bld:Qn


name: Xylose^3H post XXX challenge:SCnc:Pt:Bld:Qn


name: Xylose^30M post dose xylose PO:SCnc:Pt:Bld:Qn


name: Xylose^30M post XXX challenge:SCnc:Pt:Bld:Qn


name: Macrophages/100 leukocytes:NFr:Pt:Dial fld:Qn:Manual count


name: Mesothelial cells/100 leukocytes:NFr:Pt:Dial fld:Qn:Manual count


name: Malignant cells/100 cells:NFr:Pt:Dial fld:Qn:Manual count


name: Mean sphered cell volume:EntVol:Pt:RBC:Qn


name: Monocytoid cells/100 leukocytes:NFr:Pt:CSF:Qn:Manual count


name: Hepatitis C virus c100p+5-1-1 Ab:PrThr:Pt:Ser:Ord:IB


name: SLC14A1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Hepatitis E virus Ab:PrThr:Pt:Body fld:Ord


name: Hepatitis D virus Ab:PrThr:Pt:Body fld:Ord


name: Hepatitis C virus RNA:PrThr:Pt:Body fld:Ord:Probe.amp.tar


name: Hepatitis C virus Ab Signal/Cutoff:RelACnc:Pt:Body fld:Qn


name: Hepatitis C virus Ab:PrThr:Pt:Body fld:Ord


name: Hepatitis B virus core Ab.IgM:PrThr:Pt:Body fld:Ord


name: Hepatitis B virus surface Ag:PrThr:Pt:Body fld:Ord


name: Hepatitis A virus Ab.IgM:PrThr:Pt:Body fld:Ord


name: Hepatitis A virus Ab:PrThr:Pt:Body fld:Ord


name: Core respiratory allergens panel:-:Pt:Ser:-


name: core respiratory allergens panel in serum


name: Japanese encephalitis virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Lymphocytic choriomeningitis virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Streptococcus pneumoniae DNA & Haemophilus influenza DNA & Pseudomonas aeruginosa DNA:Prid:Pt:XXX:Nom:Probe.amp.tar


name: Brucella sp Ab:Titr:Pt:Ser:SemiQn:Aggl.standard tube


name: 17-Hydroxypregnenolone^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Pregnenolone^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Pregnenolone^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Pregnenolone^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Pregnenolone^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Pregnenolone^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Pregnenolone^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Pregnenolone^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Inner Ear 68kD Ab:Titr:Pt:Ser/Plas:SemiQn:IF


name: Leishmania sp identified:Prid:Pt:XXX:Nom:Giemsa stain


name: Leishmania sp identified:Prid:Pt:XXX:Nom:Organism specific culture


name: Muscle specific receptor tyrosine kinase Ab:SCnc:Pt:Ser:Qn


name: Establishment registration:-:-:^FDA product label:Nar


name: NDC labeler code request:-:-:^FDA product label:Nar


name: Inactive ingredient section:-:-:^FDA product label:Nar


name: Platelet aggregation.adenosine diphosphate induced^10 umol/L:PrThr:Pt:PRP:Ord


name: Herpes virus 6 Ab.IgG & IgM:Imp:Pt:Ser:Nar


name: Oxygen saturation:MFr:Pt:BldV:Qn:Calculated from oxygen partial pressure


name: Oxygen saturation:MFr:Pt:BldC:Qn:Calculated from oxygen partial pressure


name: Oxygen saturation:MFr:Pt:BldA:Qn:Calculated from oxygen partial pressure


name: Chlamydia trachomatis L2 Ab.IgA & IgG & IgM:Imp:Pt:Ser:Nom


name: Urea nitrogen renal clearance:VRat:24H:Urine+Ser/Plas:Qn


name: Blastomyces dermatitidis Ab:PrThr:Pt:CSF:Ord:Immune diffusion


name: Borrelia burgdorferi 49736 Ab.IgM:ACnc:Pt:Ser:Qn:IA


name: Borrelia burgdorferi 49736 Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Borrelia burgdorferi 49736 Ab.IgA:ACnc:Pt:Ser:Qn:IA


name: Borrelia burgdorferi G39_40 Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 49736 Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi Ab.IgA & IgG & IgM:Imp:Pt:Ser:Nom:IA


name: Purkinje cell cytoplasmic type Tr Ab:Titr:Pt:CSF:SemiQn


name: Jo-1 extractable nuclear Ab:PrThr:Pt:CSF:Ord


name: ATP7B gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: POMT1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: POMT2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: RAI1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Giardia lamblia Ab.IgA & IgG & IgM:Imp:Pt:Ser/Plas:Nom


name: Helicobacter pylori Ab.IgA & IgG & IgM:Imp:Pt:Ser/Plas:Nom


name: Muscle specific receptor tyrosine kinase Ab:Titr:Pt:Ser/Plas:SemiQn


name: Trypanosoma cruzi Ab.IgG & IgM:Imp:Pt:Ser/Plas:Nom


name: Glucose^2.5H post dose fructose PO:MCnc:Pt:Ser/Plas:Qn


name: Glucose^1.5H post dose fructose PO:MCnc:Pt:Ser/Plas:Qn


name: Glucose^3H post dose fructose PO:MCnc:Pt:Ser/Plas:Qn


name: Glucose^2H post dose fructose PO:MCnc:Pt:Ser/Plas:Qn


name: F9 gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: HEXA gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: YY1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: CFH gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: HIV 1 RNA:LnCnc:Pt:Ser/Plas:Qn:Probe.amp.tar detection limit = 0.5 log copies/mL


name: Drugs of abuse 7 & Alcohol & Tricyclics panel:-:Pt:Urine:-:Screen


name: Dengue virus Ab.IgG & IgM:Imp:Pt:Ser:Nom


name: HIV 2 Ab Signal/Cutoff:RelACnc:Pt:Ser/Plas:Qn:IA


name: Blastomyces dermatitidis Ab:Titr:Pt:Ser:SemiQn:Immune diffusion


name: Coccidioides sp Ab:Titr:Pt:Ser:SemiQn:Immune diffusion


name: Histoplasma capsulatum mycelial phase Ab:Titr:Pt:Ser:SemiQn:Immune diffusion


name: Xylose^1H post 5 g xylose PO:MCnc:Pt:Ser/Plas:Qn


name: Coxiella burnetii phase 1 Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Coxiella burnetii phase 1 Ab.IgM:ACnc:Pt:Ser:Qn:IA


name: Coxiella burnetii phase 2 Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Coxiella burnetii phase 2 Ab.IgM:ACnc:Pt:Ser:Qn:IA


name: Hepatitis C virus Ab.IgM:ACnc:Pt:Ser:Qn:IA


name: (Clupea harengus+Gadus morhua+Pleuronectes platessa+Scomber scombrus) Ab.IgE:ACnc:Pt:Ser:Qn


name: Brucella abortus Ab:PrThr:Pt:CSF:Ord:Aggl.plate.buffered acidified


name: Angiotensin converting enzyme:CCnc:Pt:Plr fld:Qn


name: Admission history and physical note:Find:Pt:{Setting}:Doc:{Role}


name: Physical findings:Find:Pt:Head & Ears & Eyes & Nose & Throat:Doc:Observed


name: Consultation note:Find:Pt:Long term care facility:Doc:{Role}


name: Staphylococcus aureus TSST-1 Ab.IgE:ACnc:Pt:Ser:Qn


name: Budgerigar serum proteins+feathers+droppings Ab.IgG:PrThr:Pt:Ser:Ord


name: Pigeon serum proteins+feathers+droppings Ab.IgG:PrThr:Pt:Ser:Ord


name: Parrot serum proteins+feathers+droppings Ab.IgG:PrThr:Pt:Ser:Ord


name: (Alternaria alternata+Cladosporium herbarum+Mucor racemosus+Penicillium notatum) Ab.IgG:PrThr:Pt:Ser:Ord:Multidisk


name: (Saccharopolyspora rectivirgula+Thermoactinomyces vulgaris) Ab.IgG:PrThr:Pt:Ser:Ord:Multidisk


name: Varicella zoster virus immune globulin units given:Num:Pt:^BPU:Qn


name: Transfuse fresh frozen plasma units:Num:Pt:^BPU:Qn


name: Fresh frozen plasma units given:Num:Pt:^BPU:Qn


name: Transfuse packed erythrocytes units:Num:Pt:^BPU:Qn


name: Packed erythrocytes units given:Num:Pt:^BPU:Qn


name: Transfuse whole blood units:Num:Pt:^BPU:Qn


name: Transfuse pooled platelets units:Num:Pt:^BPU:Qn


name: Transfuse whole blood autologous units:Num:Pt:^BPU:Qn


name: Autologous whole blood units given:Num:Pt:^BPU:Qn


name: Transfuse Rh immune globulin units:Num:Pt:^BPU:Qn


name: Rh immune globulin units given:Num:Pt:^BPU:Qn


name: Transfuse factor VIII units:Num:Pt:^BPU:Qn


name: Property and casualty state mandated forms attachment:Find:Pt:^Patient:Doc


name: Property and casualty state mandated forms attachment


name: Tax ID number - IRS form W9 attachment:Find:Pt:^Patient:Doc


name: Employee assistance program attachment:Find:Pt:^Patient:Doc


name: Extra attendants information:Cmplx:Pt:Ambulance transport:Set


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Date range (from/through) DateRange


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Date range (from/through) of hospitalization leading to treatment


name: Referral information:Cmplx:Pt:Alcohol-substance abuse rehabilitation treatment plan:Set


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Referral information (narrative)


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Referring person name


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Referring person identifier


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Date patient referred for treatment


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Communication to referring physician indicator


name: Responsible attending physician information:Cmplx:Pt:Alcohol-substance abuse rehabilitation treatment plan:Set


name: Responsible rehabilitation professional information:Cmplx:Pt:Alcohol-substance abuse rehabilitation treatment plan:Set


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Medication rate Flow


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Medication timing TQ2


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Date range certifying the plan of care DateRange


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Physician certification statement (narrative)


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Actual start of care date


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Past medical history (narrative)


name: Level of function:Cmplx:Pt:Alcohol-substance abuse rehabilitation treatment plan:Set


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Prior level of function (narrative)


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Current level of function (narrative)


name: Assessment information:Cmplx:Pt:Alcohol-substance abuse rehabilitation treatment plan:Set


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Assessment (narrative)


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Assessment indicator


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Treatment encounter (narrative)


name: Progress note+attainment of goals:Cmplx:Pt:Alcohol-substance abuse rehabilitation treatment plan:Set


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan Progress note and attainment of goals date range


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Chief complaint+Reason for relapse if known (narrative)


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Past treatment attempts (narrative)


name: Follow-up approach:Cmplx:Pt:Alcohol-substance abuse rehabilitation treatment plan:Set


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Level of patient participation (narrative)


name: Deprecated Skilled nursing treatment plan, Date patient referred for treatment


name: Responsible attending physician information:Cmplx:Pt:Skilled nursing treatment plan:Set


name: Responsible rehabilitation professional information:Cmplx:Pt:Skilled nursing treatment plan:Set


name: Deprecated Skilled nursing treatment plan, Medication rate Flow


name: Deprecated Skilled nursing treatment plan, Medication timing TQ2


name: Deprecated Skilled nursing treatment plan, Date range certifying the plan of care DateRange


name: Deprecated Skilled nursing treatment plan, Physician certification statement (narrative)


name: Deprecated Skilled nursing treatment plan, Actual start of care date


name: Deprecated Skilled nursing treatment plan, Past medical history (narrative)


name: Level of function:Cmplx:Pt:Skilled nursing treatment plan:Set


name: Transfuse factor IX units:Num:Pt:^BPU:Qn


name: Transfuse cryoprecipitate poor plasma units:Num:Pt:^BPU:Qn


name: Deprecated Fresh frozen plasma units given [#]


name: Healthcare associated infection report - recommended CDA R2 sections:-:Pt:{Setting}:-


name: Healthcare Associated Infection report:Find:Pt:{Setting}:Doc:{Role}


name: Giardia lamblia+Cryptosporidium sp Ag^3rd specimen:PrThr:Pt:Stool:Ord


name: Giardia lamblia+Cryptosporidium sp Ag^2nd specimen:PrThr:Pt:Stool:Ord


name: Hepatitis A virus Ab.IgG+IgM:PrThr:Pt:Ser:Ord


name: Hepatitis B virus core Ab.IgG+IgM:PrThr:Pt:Ser:Ord


name: Herpes simplex virus Ab.IgG:Titr:Pt:Ser:SemiQn:IA


name: Herpes simplex virus 1 Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IA


name: Legionella sp Ab^2nd specimen:Titr:Pt:Ser:SemiQn


name: Nucleated cells:NCnc:Pt:Periton fld:Qn:Manual count


name: Other cells/100 leukocytes:NFr:Pt:Bronchial:Qn:Manual count


name: Ribonucleoprotein extractable nuclear Ab:ACnc:Pt:Ser:Qn:IA


name: Escherichia coli shiga-like toxin 1:PrThr:Pt:Stool:Ord:IA


name: Package label.Back panel:-:-:^FDA product label:Nar


name: Package label.Side panel.right:-:-:^FDA product label:Nar


name: Package label.Side panel.left:-:-:^FDA product label:Nar


name: Package label.Side panel:-:-:^FDA product label:Nar


name: Package label.Principal display panel:-:-:^FDA product label:Nar


name: Package label.Top panel:-:-:^FDA product label:Nar


name: Package label.Bottom panel:-:-:^FDA product label:Nar


name: Package label.Flap panel:-:-:^FDA product label:Nar


name: Deprecated History of trisomy 21 [Finding] Narrative


name: UGT1A1 gene allele 1:Prid:Pt:Bld/Tiss:Nom:Molgen


name: UGT1A1 gene allele 2:Prid:Pt:Bld/Tiss:Nom:Molgen


name: DNA region analysis test coverage panel:-:Pt:Bld/Tiss:-:Molgen


name: Placer DNA analysis test identifier:ID:Pt:Bld/Tiss:Nom:Molgen


name: Transcript reference sequence identifier:ID:Pt:Bld/Tiss:Nom


name: Transcript reference sequence identifier


name: DNA region of interest:NumRange:Pt:Bld/Tiss:Nom:Molgen


name: DNA marker results panel:-:Pt:Bld/Tiss:-:Molgen


name: Drug efficacy sequence variation interpretation:Imp:Pt:Bld/Tiss:Ord:Molgen


name: Pharmacogenetic DNA analysis panel:-:Pt:Bld/Tiss:-:Molgen


name: Pharmacogenetic deoxyribonucleic acid analysis panel


name: Drug efficacy analysis overall interpretation:Imp:Pt:Bld/Tiss:Nom:Molgen


name: Drug efficacy analysis overall interpretation


name: Genetic disease DNA analysis panel:-:Pt:Bld/Tiss:-:Molgen


name: Genetic disease analysis overall interpretation:Imp:Pt:Bld/Tiss:Nom:Molgen


name: Genetic analysis summary report:Find:Pt:Bld/Tiss:Doc:Molgen


name: Gene product metabolic activity interpretation:Imp:Pt:Bld/Tiss:Ord:Molgen


name: Drug metabolism analysis overall interpretation


name: Individual allele results panel:-:Pt:Bld/Tiss:-:Molgen


name: Bacillus anthracis capsule Ag:PrThr:Pt:XXX:Ord:IF


name: Glomerular basement membrane Ab:MCnc:Pt:Ser:Qn


name: Referral lab test panel:-:Pt:Referral lab test:-


name: Metanephrine & Normetanephrine panel:-:Pt:Urine:-


name: Rationale for type of transport:Type:Pt:Ambulance transport:Nar


name: Distance and time transported information:Cmplx:Pt:Ambulance transport:Set


name: Distance transported - loaded indicator:Arb:Pt:Ambulance transport:Ord


name: Rationale for excess or additional mileage:Find:Pt:Ambulance transport:Nom


name: Time ambulance arrived at scene:TmStp:Pt:Ambulance transport:Qn


name: Origination site latitude:Angle:Pt:Ambulance transport:Qn


name: Origination site longitude:Angle:Pt:Ambulance transport:Qn


name: Destination site latitude:Angle:Pt:Ambulance transport:Qn


name: Destination site longitude:Angle:Pt:Ambulance transport:Qn


name: Rationale for wait time:Cmplx:Pt:Ambulance transport:Set


name: Rationale for wait time:Find:Pt:Ambulance transport:Nom


name: Rationale for wait time:Find:Pt:Ambulance transport:Nar


name: Number of patients:Num:Pt:Ambulance transport:Qn


name: Reason for multiple patients:Find:Pt:Ambulance transport:Nar


name: Other patients information:Cmplx:Pt:Ambulance transport:Set


name: Other patient name:Pn:Pt:Ambulance transport:Nom


name: Other patient identifier:ID:Pt:Ambulance transport:Nom


name: Receiving individual accepting responsibility for patient:Cmplx:Pt:Ambulance transport:Set


name: Receiving individual accepting responsibility for patient:Pn:Pt:Ambulance transport:Nom


name: Receiving individual accepting responsibility for patient:ID:Pt:Ambulance transport:Nom


name: Ordering practitioner or agency:Cmplx:Pt:Ambulance transport:Set


name: Physician certification for transport information:Cmplx:Pt:Ambulance transport:Set


name: Physician certification for transport information


name: Physician certification for transport statement:Find:Pt:Ambulance transport:Nar


name: Physician certification for transport statement


name: Physician certification for transport indicator:Arb:Pt:Ambulance transport:Ord


name: Physician certification for transport indicator


name: Description of services performed to support level of service:Find:Pt:Ambulance transport:Nar


name: Medical reason for unscheduled trip:Imp:Pt:Ambulance transport:Nom


name: Justification for extra attendants:Find:Pt:Ambulance transport:Nar


name: Type of extra attendant(s):Type:Pt:Ambulance transport:Nom


name: Origination site name and address:Cmplx:Pt:Ambulance transport:Set


name: Rationale for choice of destination:Type:Pt:Ambulance transport:Nom


name: Confined to bed or chair^at ambulance transport:Arb:Pt:^Patient:Ord


name: Destination site name & address:Cmplx:Pt:Ambulance transport:Set


name: Explanation of benefits attachment:Find:Pt:^Patient:Doc


name: Explanation of benefits to subscriber attachment:Find:Pt:^Patient:Doc


name: Explanation of benefits to subscriber attachment


name: Appeal denial letter attachment:Find:Pt:^Patient:Doc


name: Notice of Discharge Medicare Appeal Rights Form attachment:Find:Pt:^Patient:Doc


name: Notice of Discharge Medicare Appeal Rights Form attachment


name: Past filing limit justification attachment:Find:Pt:^Patient:Doc


name: Past filing limit justification attachment


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Next plan of treatment (narrative) Text


name: Deprecated Alcohol-substance abuse rehabilitation treatment plan, Date range (from/through) of next planned treatment DateRange


name: C little o super little b Ab:PrThr:Pt:Ser/Plas:Ord


name: C little o super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: Blood product unit 4 expiration:TmStp:Pt:^BPU:Qn


name: Blood product unit 3 expiration:TmStp:Pt:^BPU:Qn


name: Blood product unit 2 expiration:TmStp:Pt:^BPU:Qn


name: Blood product unit 1 expiration:TmStp:Pt:^BPU:Qn


name: Direct antiglobulin test.IgG specific reagent:PrThr:Pt:RBCCo:Ord


name: Date blood product unit received:TmStp:Pt:^BPU:Qn


name: Pooled platelets units available:Num:Pt:^BPU:Qn


name: Coagulation tissue factor induced.factor substitution^after addition of normal plasma 1H post incubation separate tubes:Time:Pt:PPP:Qn:Coag


name: Coagulation tissue factor induced.INR^post heparin neutralization:RelTime:Pt:PPP:Qn:Coag


name: t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: Coagulation dilute Russell viper venom induced.factor substitution^immediately after 4:1 addition of normal plasma:Time:Pt:PPP:Qn:Coag


name: Coagulation surface induced.lupus sensitive.factor substitution^immediately after 4:1 addition of normal plasma:Time:Pt:PPP:Qn:Coag


name: t(9;22)(q34.1;q11)(ABL1,BCR) transcript detection panel:-:Pt:Bld/Tiss:-:Molgen


name: t(9;22)(q34.1;q11)(ABL1,BCR) transcript detection panel


name: Deprecated Pulmonary therapy treatment plan, New/revised


name: Deprecated Pulmonary therapy treatment plan, Primary diagnosis Identifier


name: Deprecated Pulmonary therapy treatment plan, Date onset or exacerbation of primary diagnosis


name: Deprecated Pulmonary therapy treatment plan, Date range (from/through) DateRange


name: Deprecated Pulmonary therapy treatment plan, Visit frequency TQ2


name: Deprecated Pulmonary therapy treatment plan, Diagnosis addressed by plan Identifier


name: Author of treatment plan:Cmplx:Pt:Pulmonary therapy treatment plan:Set


name: Deprecated Pulmonary therapy treatment plan, Author name


name: Deprecated Pulmonary therapy treatment plan, Author ID Identifier


name: Deprecated Pulmonary therapy treatment plan, Author profession Identifier


name: Deprecated Pulmonary therapy treatment plan, Date range (from/through) of hospitalization leading to treatment


name: Deprecated Pulmonary therapy treatment plan, Continuation status


name: Referral information:Cmplx:Pt:Pulmonary therapy treatment plan:Set


name: Deprecated Pulmonary therapy treatment plan, Referral information (narrative)


name: Deprecated Pulmonary therapy treatment plan, Referring person name


name: Deprecated Pulmonary therapy treatment plan, Referring person identifier


name: Deprecated Pulmonary therapy treatment plan, Date patient referred for treatment


name: Responsible attending physician information:Cmplx:Pt:Pulmonary therapy treatment plan:Set


name: Deprecated Pulmonary therapy treatment plan, Signature of responsible attending physician on file


name: Deprecated Pulmonary therapy treatment plan, Date attending MD signed Date and time


name: Responsible rehabilitation professional information:Cmplx:Pt:Pulmonary therapy treatment plan:Set


name: Deprecated Pulmonary therapy treatment plan, Signature of responsible rehabilitation professional on file


name: Deprecated Pulmonary therapy treatment plan, Date rehabilitation professional signed Date and time


name: Medication administered:Cmplx:Pt:Pulmonary therapy treatment:Set


name: Deprecated Pulmonary therapy treatment plan, Medication name + identifier Identifier


name: Deprecated Pulmonary therapy treatment plan, Medication Dosage


name: Deprecated Pulmonary therapy treatment plan, Medication rate Flow


name: Deprecated Pulmonary therapy treatment plan, Medication timing TQ2


name: Deprecated Pulmonary therapy treatment plan, Medication route Identifier


name: Deprecated Pulmonary therapy treatment plan, Prognosis for rehabilitation


name: Deprecated Pulmonary therapy treatment plan, Date range certifying the plan of care DateRange


name: Deprecated Pulmonary therapy treatment plan, Physician certification statement (narrative)


name: Deprecated Pulmonary therapy treatment plan, Actual start of care date


name: Deprecated Pulmonary therapy treatment plan, Past medical history (narrative)


name: Level of function:Cmplx:Pt:Pulmonary therapy treatment plan:Set


name: Deprecated Pulmonary therapy treatment plan, Prior level of function (narrative)


name: Deprecated Pulmonary therapy treatment plan, Current level of function (narrative)


name: Assessment information:Cmplx:Pt:Pulmonary therapy treatment plan:Set


name: Deprecated Pulmonary therapy treatment plan, Assessment (narrative)


name: Deprecated Pulmonary therapy treatment plan, Assessment indicator


name: Deprecated Pulmonary therapy treatment plan, Plan of treatment (narrative)


name: Deprecated Pulmonary therapy treatment plan, Treatment encounter (narrative)


name: Progress note+attainment of goals:Cmplx:Pt:Pulmonary therapy treatment plan:Set


name: Deprecated Pulmonary therapy treatment plan Progress note and attainment of goals (narrative)


name: Deprecated Pulmonary therapy treatment plan Progress note and attainment of goals date range


name: Deprecated Pulmonary therapy treatment plan, Reason to continue (narrative)


name: Deprecated Pulmonary therapy treatment plan, Justification (narrative)


name: Rehabilitation.pulmonary therapy service attachment:Find:Pt:{Setting}:Doc:{Role}


name: Deprecated Pulmonary therapy treatment plan, Functional status (narrative)


name: Deprecated Pulmonary therapy treatment plan, Activities permitted (narrative)


name: Deprecated Pulmonary therapy treatment plan, Mental status (narrative)


name: Deprecated Pulmonary therapy treatment plan, Additional assessment (narrative)


name: Deprecated Cardiac rehabilitation treatment plan, Date range (from/through) DateRange


name: Deprecated Cardiac rehabilitation treatment plan, Date range (from/through) of hospitalization leading to treatment


name: Referral information:Cmplx:Pt:Cardiac rehabilitation treatment plan:Set


name: Deprecated Cardiac rehabilitation treatment plan, Referral information (narrative)


name: Deprecated Cardiac rehabilitation treatment plan, Referring person name


name: Deprecated Cardiac rehabilitation treatment plan, Referring person identifier


name: Deprecated Cardiac rehabilitation treatment plan, Date patient referred for treatment


name: Responsible attending physician information:Cmplx:Pt:Cardiac rehabilitation treatment plan:Set


name: Responsible rehabilitation professional information:Cmplx:Pt:Cardiac rehabilitation treatment plan:Set


name: Deprecated Cardiac rehabilitation treatment plan, Medication rate Flow


name: Deprecated Cardiac rehabilitation treatment plan, Medication timing TQ2


name: Deprecated Cardiac rehabilitation treatment plan, Date range certifying the plan of care DateRange


name: Deprecated Cardiac rehabilitation treatment plan, Physician certification statement (narrative)


name: Deprecated Cardiac rehabilitation treatment plan, Actual start of care date


name: Deprecated Cardiac rehabilitation treatment plan, Past medical history (narrative)


name: Level of function:Cmplx:Pt:Cardiac rehabilitation treatment plan:Set


name: Deprecated Cardiac rehabilitation treatment plan, Prior level of function (narrative)


name: Deprecated Cardiac rehabilitation treatment plan, Current level of function (narrative)


name: Assessment information:Cmplx:Pt:Cardiac rehabilitation treatment plan:Set


name: Deprecated Cardiac rehabilitation treatment plan, Assessment indicator


name: Deprecated Cardiac rehabilitation treatment plan, Functional status (narrative)


name: Deprecated Cardiac rehabilitation treatment plan, Activities permitted (narrative)


name: Deprecated Cardiac rehabilitation treatment plan, Mental status (narrative)


name: Deprecated Cardiac rehabilitation treatment plan, Additional assessment (narrative)


name: Deprecated Cardiac rehabilitation treatment plan, Treatment encounter (narrative)


name: Progress note+attainment of goals:Cmplx:Pt:Cardiac rehabilitation treatment plan:Set


name: Deprecated Cardiac rehabilitation treatment plan Progress note and attainment of goals date range


name: Deprecated Medical social services treatment plan, Date range (from/through) DateRange


name: Deprecated Medical social services treatment plan, Date range (from/through) of hospitalization leading to treatment


name: Referral information:Cmplx:Pt:Medical social services treatment plan:Set


name: Deprecated Medical social services treatment plan, Referral information (narrative)


name: Deprecated Medical social services treatment plan, Referring person name


name: Deprecated Medical social services treatment plan, Referring person identifier


name: Deprecated Medical social services treatment plan, Date patient referred for treatment


name: Responsible attending physician information:Cmplx:Pt:Medical social services treatment plan:Set


name: Responsible rehabilitation professional information:Cmplx:Pt:Medical social services treatment plan:Set


name: Deprecated Medical social services treatment plan, Medication rate Flow


name: Deprecated Medical social services treatment plan, Medication timing TQ2


name: Deprecated Medical social services treatment plan, Date range certifying the plan of care DateRange


name: Deprecated Medical social services treatment plan, Physician certification statement (narrative)


name: Deprecated Medical social services treatment plan, Actual start of care date


name: Deprecated Medical social services treatment plan, Past medical history (narrative)


name: Level of function:Cmplx:Pt:Medical social services treatment plan:Set


name: Deprecated Medical social services treatment plan, Prior level of function (narrative)


name: Deprecated Medical social services treatment plan, Current level of function (narrative)


name: Assessment information:Cmplx:Pt:Medical social services treatment plan:Set


name: Deprecated Medical social services treatment plan, Assessment indicator


name: Deprecated Medical social services treatment plan, Functional status (narrative)


name: Deprecated Medical social services treatment plan, Activities permitted (narrative)


name: Deprecated Medical social services treatment plan, Mental status (narrative)


name: Deprecated Medical social services treatment plan, Additional assessment (narrative)


name: Deprecated Medical social services treatment plan, Treatment encounter (narrative)


name: Progress note+attainment of goals:Cmplx:Pt:Medical social services treatment plan:Set


name: Deprecated Medical social services treatment plan Progress note and attainment of goals date range


name: Deprecated Occupational therapy treatment plan, Date range (from/through) DateRange


name: Referral information:Cmplx:Pt:Occupational therapy treatment plan:Set


name: Deprecated Occupational therapy treatment plan, Referral information (narrative)


name: Deprecated Occupational therapy treatment plan, Referring person name


name: Deprecated Occupational therapy treatment plan, Referring person identifier


name: Responsible attending physicican information:Cmplx:Pt:Occupational therapy treatment plan:Set


name: Responsible attending physicican information


name: Responsible rehabilitation professional information:Cmplx:Pt:Occupational therapy treatment plan:Set


name: Deprecated Occupational therapy treatment plan, Medication timing TQ2


name: Deprecated Occupational therapy treatment plan, Date range certifying the plan of care DateRange


name: Deprecated Occupational therapy treatment plan, Physician certification statement (narrative)


name: Deprecated Occupational therapy treatment plan, Actual start of care date


name: Deprecated Occupational therapy treatment plan, Past medical history (narrative)


name: Level of function:Cmplx:Pt:Occupational therapy treatment plan:Set


name: Deprecated Occupational therapy treatment plan, Prior level of function (narrative)


name: Deprecated Occupational therapy treatment plan, Current level of function (narrative)


name: Assessment information:Cmplx:Pt:Occupational therapy treatment plan:Set


name: Deprecated Occupational therapy treatment plan, Assessment indicator


name: Deprecated Occupational therapy treatment plan, Functional status (narrative)


name: Deprecated Occupational therapy treatment plan, Activities permitted (narrative)


name: Deprecated Occupational therapy treatment plan, Mental status (narrative)


name: Deprecated Occupational therapy treatment plan, Additional assessment (narrative)


name: Deprecated Occupational therapy treatment plan, Treatment encounter (narrative)


name: Individual education plan information:Cmplx:Pt:Occupational therapy treatment plan:Set


name: Deprecated Occupational therapy treatment plan, Defined school year DateRange


name: Deprecated Occupational therapy treatment plan, Individual education plan (narrative)


name: Deprecated Occupational therapy treatment plan Progress note and attainment of goals date range


name: Deprecated Occupational therapy treatment plan, Date patient referred for treatment


name: Deprecated Occupational therapy treatment plan, Medication rate Flow


name: Deprecated Physical therapy treatment plan, Date range (from/through) DateRange


name: Deprecated Physical therapy treatment plan, Date range (from/through) of hospitalization leading to treatment


name: Referral information:Cmplx:Pt:Physical therapy treatment plan:Set


name: Deprecated Physical therapy treatment plan, Referral information (narrative)


name: Deprecated Physical therapy treatment plan, Referring person name


name: Deprecated Physical therapy treatment plan, Referring person identifier


name: Deprecated Physical therapy treatment plan, Date patient referred for treatment


name: Responsible attending physician information:Cmplx:Pt:Physical therapy treatment plan:Set


name: Responsible rehabilitation professional information:Cmplx:Pt:Physical therapy treatment plan:Set


name: Deprecated Physical therapy treatment plan, Medication rate Flow


name: Deprecated Physical therapy treatment plan, Medication timing TQ2


name: Deprecated Physical therapy treatment plan, Date range certifying the plan of care DateRange


name: Deprecated Physical therapy treatment plan, Physician certification statement (narrative)


name: Deprecated Physical therapy treatment plan, Actual start of care date


name: Deprecated Physical therapy treatment plan, Past medical history (narrative)


name: Level of function:Cmplx:Pt:Physical therapy treatment plan:Set


name: Deprecated Physical therapy treatment plan, Prior level of function (narrative)


name: Deprecated Physical therapy treatment plan, Current level of function (narrative)


name: Assessment information:Cmplx:Pt:Physical therapy treatment plan:Set


name: Deprecated Physical therapy treatment plan, Assessment indicator


name: Deprecated Physical therapy treatment plan, Functional status (narrative)


name: Deprecated Physical therapy treatment plan, Activities permitted (narrative)


name: Deprecated Physical therapy treatment plan, Mental status (narrative)


name: Deprecated Physical therapy treatment plan, Additional assessment (narrative)


name: Deprecated Physical therapy treatment plan, Treatment encounter (narrative)


name: Individual education plan information:Cmplx:Pt:Physical therapy treatment plan:Set


name: Deprecated Physical therapy treatment plan, Defined school year DateRange


name: Deprecated Physical therapy treatment plan, Individual education plan (narrative)


name: Progress note+attainment of goals:Cmplx:Pt:Physical therapy treatment plan:Set


name: Deprecated Physical therapy treatment plan Progress note and attainment of goals date range


name: Deprecated Psychiatric rehabilitation treatment plan, Date range (from/through) DateRange


name: Deprecated Psychiatric rehabilitation treatment plan, Diagnosis addressed by plan Identifier


name: Deprecated Psychiatric rehabilitation treatment plan, Date range (from/through) of hospitalization leading to treatment


name: Referral information:Cmplx:Pt:Psychiatric rehabilitation treatment plan:Set


name: Deprecated Psychiatric rehabilitation treatment plan, Referral information (narrative)


name: Deprecated Psychiatric rehabilitation treatment plan, Referring person name


name: Deprecated Psychiatric rehabilitation treatment plan, Referring person identifier


name: Deprecated Psychiatric rehabilitation treatment plan, Date patient referred for treatment


name: Deprecated Psychiatric rehabilitation treatment plan, Communication to referring physician indicator


name: Responsible attending physician information:Cmplx:Pt:Psychiatric rehabilitation treatment plan:Set


name: Responsible rehabilitation professional information:Cmplx:Pt:Psychiatric rehabilitation treatment plan:Set


name: Deprecated Psychiatric rehabilitation treatment plan, Medication name + identifier Identifier


name: Deprecated Psychiatric rehabilitation treatment plan, Medication Dosage


name: Deprecated Psychiatric rehabilitation treatment plan, Medication rate Flow


name: Deprecated Psychiatric rehabilitation treatment plan, Medication timing TQ2


name: Deprecated Psychiatric rehabilitation treatment plan, Date range certifying the plan of care DateRange


name: Deprecated Psychiatric rehabilitation treatment plan, Physician certification statement (narrative)


name: Deprecated Psychiatric rehabilitation treatment plan, Actual start of care date


name: Assessment information:Cmplx:Pt:Respiratory therapy treatment plan:Set


name: Deprecated Respiratory therapy treatment plan, Assessment indicator


name: Deprecated Respiratory therapy treatment plan, Assessment (narrative)


name: Deprecated Respiratory therapy treatment plan, Treatment encounter (narrative)


name: Progress note+attainment of goals:Cmplx:Pt:Respiratory therapy treatment plan:Set


name: Deprecated Respiratory therapy treatment plan Progress note and attainment of goals date range


name: Deprecated Skilled nursing treatment plan, Date range (from/through) of hospitalization leading to treatment


name: Deprecated Skilled nursing treatment plan, Date range (from/through) DateRange


name: Referral information:Cmplx:Pt:Skilled nursing treatment plan:Set


name: Deprecated Skilled nursing treatment plan, Referral information (narrative)


name: Deprecated Skilled nursing treatment plan, Referring person name


name: Deprecated Skilled nursing treatment plan, Referring person identifier


name: Deprecated Skilled nursing treatment plan, Prior level of function (narrative)


name: Deprecated Skilled nursing treatment plan, Current level of function (narrative)


name: Assessment information:Cmplx:Pt:Skilled nursing treatment plan:Set


name: Deprecated Skilled nursing treatment plan, Assessment indicator


name: Deprecated Skilled nursing treatment plan, Functional status (narrative)


name: Deprecated Skilled nursing treatment plan, Activities permitted (narrative)


name: Deprecated Skilled nursing treatment plan, Mental status (narrative)


name: Deprecated Skilled nursing treatment plan, Additional assessment (narrative)


name: Deprecated Skilled nursing treatment plan, Treatment encounter (narrative)


name: Deprecated Skilled nursing treatment plan Progress note and attainment of goals date range


name: Progress note+attainment of goals:Cmplx:Pt:Skilled nursing treatment plan:Set


name: Deprecated Speech therapy treatment plan, Date range (from/through) DateRange


name: Deprecated Speech therapy treatment plan, Date range (from/through) of hospitalization leading to treatment


name: Referral information:Cmplx:Pt:Speech therapy treatment plan:Set


name: Deprecated Speech therapy treatment plan, Referral information (narrative)


name: Deprecated Speech therapy treatment plan, Referring person name


name: Deprecated Speech therapy treatment plan, Referring person identifier


name: Deprecated Speech therapy treatment plan, Date patient referred for treatment


name: Responsible attending physician information:Cmplx:Pt:Speech therapy treatment plan:Set


name: Responsible rehabilitation professional information:Cmplx:Pt:Speech therapy treatment plan:Set


name: Deprecated Speech therapy treatment plan, Medication rate Flow


name: Deprecated Occupational therapy treatment plan, Medication name Identifier


name: Deprecated Occupational therapy treatment plan, Medication name ID Identifier


name: Volume expired during 2.0 s of forced expiration/Volume.forced expiration.total:VFr:Pt:Respiratory system:Qn


name: Brief interview for mental status:-:Pt:^Patient:-:BIMS


name: Genetic disease analysis overall diagnostic interpretation


name: Genetic disease analysis overall carrier interpretation:Imp:Pt:Bld/Tiss:Nom:Molgen


name: Genetic disease analysis overall carrier interpretation


name: Drug metabolism sequence variation interpretation:Imp:Pt:Bld/Tiss:Ord:Molgen


name: DNA region of interest panel:-:Pt:Bld/Tiss:-:Molgen


name: DNA marker assessed panel:-:Pt:Bld/Tiss:-:Molgen


name: DNA marker analysis test coverage panel:-:Pt:Bld/Tiss:-:Molgen


name: Activated protein C resistance:PrThr:Pt:PPP:Ord:Coag


name: Coagulation surface induced.factor sensitive:Time:Pt:PPP:Qn:Coag


name: Coagulation tissue factor induced.PIVKA insensitive actual/Normal:RelTime:Pt:BldC:Qn:Coag


name: Coagulation tissue factor induced.PIVKA insensitive actual/Normal:RelTime:Pt:PPP:Qn:Coag


name: Kininogen.high molecular weight activity actual/Normal:RelTime:Pt:PPP:Qn:Coag


name: Kininogen.high molecular weight activity actual/Normal


name: Coagulation surface induced.lupus sensitive:PrThr:Pt:PPP:Ord:Coag


name: Coagulation dilute Russell viper venom induced.excess phospholipid:PrThr:Pt:PPP:Ord:Coag


name: Coagulation tissue factor induced.PIVKA sensitive actual/Normal:RelTime:Pt:BldC:Qn:Coag


name: Coagulation tissue factor induced.PIVKA sensitive actual/Normal


name: Coagulation tissue factor induced.PIVKA sensitive actual/Normal:RelTime:Pt:PPP:Qn:Coag


name: Intrinsic coagulation system thromboelastography panel:-:Pt:Bld:-


name: Extrinsic coagulation system thromboelastography panel:-:Pt:Bld:-


name: Extrinsic coagulation system with fibrinolysis inhibition thromboelastography panel:-:Pt:Bld:-


name: Thromboelastography without activation panel:-:Pt:Bld:-


name: Coagulation surface induced^after addition of protein C activator+Factor V depleted plasma/Coagulation surface induced:TRto:Pt:PPP:Qn:Coag


name: Coagulation surface induced^after addition of protein C activator/Coagulation surface induced:TRto:Pt:PPP:Qn:Coag


name: Clot formation.extrinsic coagulation system activated.fibrinolysis suppressed:Time:Pt:Bld:Qn:Thromboelastography.rotational


name: Clot formation.extrinsic coagulation system activated.fibrinolysis suppressed


name: Clot formation.extrinsic coagulation system activated:Time:Pt:Bld:Qn:Thromboelastography.rotational


name: Clot formation.extrinsic coagulation system activated


name: Clot formation.intrinsic coagulation system activated:Time:Pt:Bld:Qn:Thromboelastography.rotational


name: Clot formation.intrinsic coagulation system activated


name: Clot formation.intrinsic coagulation system activated.heparin insensitive:Time:Pt:Bld:Qn:Thromboelastography.rotational


name: Clot formation.intrinsic coagulation system activated.heparin insensitive


name: Clotting time.extrinsic coagulation system activated:Time:Pt:Bld:Qn:Thromboelastography.rotational


name: Clotting time.extrinsic coagulation system activated


name: Clotting time.extrinsic coagulation system activated.fibrinolysis suppressed:Time:Pt:Bld:Qn:Thromboelastography.rotational


name: Clotting time.extrinsic coagulation system activated.fibrinolysis suppressed


name: Clotting time.intrinsic coagulation system activated.heparin insensitive:Time:Pt:Bld:Qn:Thromboelastography.rotational


name: Clotting time.intrinsic coagulation system activated.heparin insensitive


name: Clotting time.intrinsic coagulation system activated:Time:Pt:Bld:Qn:Thromboelastography.rotational


name: Clotting time.intrinsic coagulation system activated


name: Intrinsic coagulation system with heparin inhibition thromboelastography panel:-:Pt:Bld:-


name: Maximum clot firmness.extrinsic coagulation system activated.fibrinolysis suppressed:Len:Pt:Bld:Qn:Thromboelastography.rotational


name: Maximum clot firmness.extrinsic coagulation system activated.fibrinolysis suppressed


name: Maximum clot firmness.extrinsic coagulation system activated.platelets inhibited:Len:Pt:Bld:Qn:Thromboelastography.rotational


name: Maximum clot firmness.extrinsic coagulation system activated.platelets inhibited


name: Maximum clot firmness.intrinsic coagulation system activated:Len:Pt:Bld:Qn:Thromboelastography.rotational


name: Maximum clot firmness.intrinsic coagulation system activated


name: Maximum clot firmness.intrinsic coagulation system activated.heparin insensitive:Len:Pt:Bld:Qn:Thromboelastography.rotational


name: Maximum clot firmness.intrinsic coagulation system activated.heparin insensitive


name: Maximum clot firmness.extrinsic coagulation system activated:Len:Pt:Bld:Qn:Thromboelastography.rotational


name: Maximum clot firmness.extrinsic coagulation system activated


name: Maximum lysis.extrinsic coagulation system activated.fibrinolysis suppressed:LenFr:Pt:Bld:Qn:Thromboelastography.rotational


name: Maximum lysis.extrinsic coagulation system activated.fibrinolysis suppressed


name: Maximum lysis.extrinsic coagulation system activated:LenFr:Pt:Bld:Qn:Thromboelastography.rotational


name: Maximum lysis.extrinsic coagulation system activated


name: Maximum lysis.intrinsic coagulation system activated:LenFr:Pt:Bld:Qn:Thromboelastography.rotational


name: Maximum lysis.intrinsic coagulation system activated


name: Maximum lysis.intrinsic coagulation system activated.heparin insensitive:LenFr:Pt:Bld:Qn:Thromboelastography.rotational


name: Maximum lysis.intrinsic coagulation system activated.heparin insensitive


name: Guidance for percutaneous replacement of drainage catheter:Find:Pt:Abdomen:Doc:CT


name: Guidance for percutaneous replacement of drainage catheter:Find:Pt:Pelvis:Doc:CT


name: Ova & parasites^3rd specimen:Prid:Pt:XXX:Nom:Microscopy.light


name: Ova & parasites^2nd specimen:Prid:Pt:XXX:Nom:Microscopy.light


name: Nucleated cells:NCnc:Pt:Pericard fld:Qn:Automated count


name: Nucleated cells:NCnc:Pt:Dial fld:Qn:Automated count


name: Nucleated cells:NCnc:Pt:Periton fld:Qn:Automated count


name: Nucleated cells:NCnc:Pt:Plr fld:Qn:Automated count


name: Saint Louis encephalitis virus Ab.IgG:PrThr:Pt:Ser:Ord:IA


name: Eastern equine encephalitis virus Ab.IgG:PrThr:Pt:Ser:Ord:IA


name: La Crosse virus Ab.IgG:PrThr:Pt:Ser:Ord:IA


name: La Crosse virus Ab.IgM:PrThr:Pt:Ser:Ord:IA


name: La Crosse virus Ab.IgM:PrThr:Pt:CSF:Ord:IA


name: Nursing management minimum data set panel:-:Pt:Facility:-:NMMDS


name: Nursing management minimum data set panel


name: Facility unique identifier panel:-:Pt:Facility:-:NMMDS


name: State, district or territory federal abbreviation:Loc:Pt:Facility:Nom


name: State, district or territory federal abbreviation


name: Survey reporting period start date:Date:Pt:Facility:Qn


name: Survey reporting period end date:Date:Pt:Facility:Qn


name: Nursing delivery unit or service panel:-:Pt:Facility:-:NMMDS


name: Nursing unit name:ID:Pt:{Nursing unit}:Nom


name: Nursing unit cost center:ID:Pt:Nursing unit:Nom


name: Type of nursing unit or service:Type:Pt:Nursing unit:Nom:NDNQI


name: Population distribution panel:-:Pt:{Type of nursing unit or service}:-:NMMDS


name: Total patient population:Num:Pt:{Type of nursing unit or service}:Qn


name: Total population of fetal age:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age birth to 28D:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 29D to 1Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 1-4Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 5-9Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 10-14Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 15-19Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 20-24Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 25-29Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 30-34Y:NFr:Pt:{Nursing unit}^Population:Qn


name: Total population of age 35-39Y:NFr:Pt:{Nursing unit}^Population:Qn


name: World catchment area:NFr:Pt:{Nursing unit}^Population:Qn:Estimated


name: Aerospace catchment area:NFr:Pt:{Nursing unit}^Population:Qn:Estimated


name: Nautical catchment area:NFr:Pt:{Nursing unit}^Population:Qn:Estimated


name: Cells.cytoplasmic CD22/100 cells:NFr:Pt:Body fld:Qn


name: Cells.cytoplasmic CD22/100 cells:NFr:Pt:Bone mar:Qn


name: Cells.cytoplasmic CD3/100 cells:NFr:Pt:Body fld:Qn


name: Cells.cytoplasmic CD3/100 cells:NFr:Pt:Bone mar:Qn


name: PCNA extractable nuclear Ab:Titr:Pt:Ser:SemiQn:IF


name: PM-SCL extractable nuclear Ab:PrThr:Pt:Ser:Ord:IF


name: PM-SCL extractable nuclear Ab:Titr:Pt:Ser:SemiQn:IF


name: Signal recognition particle Ab:PrThr:Pt:Ser/Plas:Ord:IF


name: Signal recognition particle Ab:Titr:Pt:Ser/Plas:SemiQn:IF


name: Nursing Management Minimum Data Survey (NMMDS)


name: Brief Interview for Mental Health Status (BIMS) set


name: Surgical operation note postoperative Diagnosis


name: Surgical operation note preoperative Diagnosis


name: Surgical operation note prep time duration


name: Surgical operation note surgical complications


name: Surgical operation note surgical procedure


name: Influenza virus A RNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Influenza virus B RNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Parainfluenza virus 1 RNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Parainfluenza virus 2 RNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Parainfluenza virus 3 RNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4):SRto:Pt:Bld.dot:Qn


name: Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4)


name: Streptococcus agalactiae:PrThr:Pt:Anal:Ord:Organism specific culture


name: Staphylococcus aureus.methicillin resistant isolate:PrThr:Pt:Nose:Ord:Organism specific culture


name: (Avena sativa+Fagopyrum esculentum+Sesamum indicum+Triticum aestivum+Zea mays) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: Influenza virus B Ab:ACnc:Pt:Ser:Qn:Comp fix


name: Respiratory syncytial virus Ab:ACnc:Pt:Ser:Qn:Comp fix


name: Herpes simplex virus Ab:ACnc:Pt:Ser:Qn:Comp fix


name: Varicella zoster virus Ab:ACnc:Pt:Ser:Qn:Comp fix


name: Herpes simplex virus Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Rubella virus Ab.IgG avidity:Ratio:Pt:Ser:Qn:IA


name: Mycoplasma pneumoniae Ab:ACnc:Pt:Ser:Qn:Comp fix


name: Cells.cytoplasmic CD79a/100 cells:NFr:Pt:Body fld:Qn


name: Cells.cytoplasmic CD79a/100 cells:NFr:Pt:Bone mar:Qn


name: Cells.terminal deoxyribonucleotidyl transferase/100 cells:NFr:Pt:Bld:Qn:Flow cytometry


name: Cells.terminal deoxyribonucleotidyl transferase/100 cells:NFr:Pt:Body fld:Qn:Flow cytometry


name: Cells.terminal deoxyribonucleotidyl transferase/100 cells:NFr:Pt:Tiss:Qn:Flow cytometry


name: Nuclear Ab pattern.fine speckled:Titr:Pt:Ser:SemiQn:IF


name: Mitotic spindle apparatus Ab:Titr:Pt:Ser/Plas:SemiQn:IF


name: Mitotic spindle apparatus Ab:PrThr:Pt:Ser/Plas:Ord:IF


name: Bactericidal permeability increasing protein Ab:PrThr:Pt:Ser:Ord


name: Sjogrens syndrome-A extractable nuclear 52kD Ab:PrThr:Pt:Ser:Ord


name: Sjogrens syndrome-A extractable nuclear 52kD Ab:ACnc:Pt:Ser:Qn


name: Sjogrens syndrome-A extractable nuclear 60kD Ab:PrThr:Pt:Ser:Ord


name: Sjogrens syndrome-A extractable nuclear 60kD Ab:ACnc:Pt:Ser:Qn


name: U1 small nuclear ribonucleoprotein Ab:PrThr:Pt:Ser:Ord


name: Cyclic citrullinated peptide Ab:ACnc:Pt:Ser:Qn


name: Cyclic citrullinated peptide Ab:PrThr:Pt:Ser:Ord


name: Liver kidney microsomal Ab:PrThr:Pt:Ser:Ord:IF


name: Signal recognition particle Ab:ACnc:Pt:Ser/Plas:Qn


name: U1 small nuclear ribonucleoprotein 70kD Ab:PrThr:Pt:Ser:Ord


name: Include all data of the selected type that represents observations made two Y or less before the starting date of service:Scope.modifier.time window:Pt:X12^277:-


name: Filler DNA analysis test identifier:ID:Pt:Bld/Tiss:Nom:Molgen


name: Genetic disease sequence variation interpretation:Imp:Pt:Bld/Tiss:Nom:Molgen


name: Genetic disease sequence variation interpretation


name: DNA marker identified panel:-:Pt:Bld/Tiss:-:Molgen


name: Beta globulin+Gamma globulin:MCnc:Pt:Body fld:Qn:Electrophoresis


name: Beta globulin+Gamma globulin/Protein.total:MFr:Pt:Body fld:Qn:Electrophoresis


name: Calcium.ionized^^adjusted to pH 7.4:SCnc:Pt:Flu.nonbiological:Qn


name: Sodium urate crystals:Naric:Pt:Urine sed:Qn:Microscopy.light.HPF


name: Ammonium urate crystals:Naric:Pt:Urine sed:Qn:Microscopy.light.LPF


name: Calcium oxalate crystals:Naric:Pt:Urine sed:Qn:Microscopy.light.LPF


name: Organic acids pattern:Imp:Pt:Body fld:Nom


name: Calcium.ionized^^adjusted to pH 7.4:SCnc:Pt:BldA:Qn


name: Calcium.ionized^^adjusted to pH 7.4:SCnc:Pt:BldC:Qn


name: Calcium.ionized^^adjusted to pH 7.4:SCnc:Pt:BldV:Qn


name: 17-Hydroxyprogesterone^30M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^75M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Lutropin^45M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Follitropin^45M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Follitropin^2H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: DNA double strand Ab:PrThr:Pt:Body fld:Ord


name: 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10):SRto:Pt:Bld.dot:Qn


name: Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH):SRto:Pt:Bld.dot:Qn


name: Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8):SRto:Pt:Bld.dot:Qn


name: Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16):SRto:Pt:Bld.dot:Qn


name: Coagulation dilute Russell viper venom induced:Time:Pt:PPP^Control:Qn:Coag


name: Coagulation factor XI activated activity:ACnc:Pt:PPP:Qn:Coag


name: Coagulation tissue factor induced.factor substitution^immediately after 1:4 addition of normal plasma:Time:Pt:PPP:Qn:Coag


name: Carnitine.free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18):SRto:Pt:Bld.dot:Qn


name: Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline:SRto:Pt:Bld.dot:Qn


name: Charge ticket or encounter form attachment:Find:Pt:^Patient:Doc


name: Charge ticket or encounter form attachment


name: Advanced beneficiary notice attachment:Find:Pt:^Patient:Doc


name: Notice of privacy practices receipt attachment:Find:Pt:^Patient:Doc


name: Notice of privacy practices receipt attachment


name: Plasmodium sp lactate dehydrogenase:PrThr:Pt:Bld:Ord


name: Glomerular basement membrane Ab:Titr:Pt:Ser:SemiQn:IF


name: Glomerular basement membrane Ab:PrThr:Pt:Ser:Ord:IF


name: Amino acid newborn screen panel:SCnc:Pt:Bld.dot:-


name: Carnitine newborn screen panel:SCnc:Pt:Bld.dot:-


name: Urinalysis yeast variants panel:-:Pt:Urine:-:Computer assisted


name: Urinalysis yeast variants panel:NCnc:Pt:Urine:Qn:Computer assisted


name: Urinalysis yeast variants panel:Naric:Pt:Urine:Qn:Computer assisted


name: Urinalysis type of non-squamous epithelial cells panel:-:Pt:Urine:-:Computer assisted


name: Urinalysis type of non-squamous epithelial cells panel


name: Urinalysis type of non-squamous epithelial cells panel:NCnc:Pt:Urine:Qn:Computer assisted


name: Urinalysis type of non-squamous epithelial cells panel:Naric:Pt:Urine:Qn:Computer assisted


name: Urinalysis type of cast panel:-:Pt:Urine:-:Computer assisted


name: Casts type not specified:PrThr:Pt:Urine:Ord:Computer assisted


name: Urinalysis type of cast panel:NCnc:Pt:Urine:Qn:Computer assisted


name: Mixed cellular casts:NCnc:Pt:Urine:Qn:Computer assisted


name: Mixed cellular casts:Naric:Pt:Urine:Qn:Computer assisted


name: Urinalysis microscopic panel:Naric:Pt:Urine sed:Qn:Automated count


name: Epithelial cells.non-squamous:Naric:Pt:Urine sed:Qn:Automated count


name: Urinalysis type of crystal panel:NCnc:Pt:Urine:Qn:Computer assisted


name: Calcium oxalate crystals:NCnc:Pt:Urine:Qn:Computer assisted


name: Triple phosphate crystals:NCnc:Pt:Urine:Qn:Computer assisted


name: Calcium phosphate crystals:NCnc:Pt:Urine:Qn:Computer assisted


name: Calcium carbonate crystals:NCnc:Pt:Urine:Qn:Computer assisted


name: Urinalysis type of crystal panel:Naric:Pt:Urine:Qn:Computer assisted


name: Calcium oxalate crystals:Naric:Pt:Urine:Qn:Computer assisted


name: Triple phosphate crystals:Naric:Pt:Urine:Qn:Computer assisted


name: Calcium phosphate crystals:Naric:Pt:Urine:Qn:Computer assisted


name: Calcium carbonate crystals:Naric:Pt:Urine:Qn:Computer assisted


name: Casts type not specified:NCnc:Pt:Urine:Qn:Computer assisted


name: Urinalysis type of crystal panel:-:Pt:Urine:-:Computer assisted


name: Urinalysis type of cast panel:Naric:Pt:Urine:Qn:Computer assisted


name: Urinalysis other formed elements panel:-:Pt:Urine:-:Computer assisted


name: Casts type not specified:Naric:Pt:Urine:Qn:Computer assisted


name: Urinalysis other formed elements panel:NCnc:Pt:Urine:Qn:Computer assisted


name: Oval fat bodies (globules):NCnc:Pt:Urine:Qn:Computer assisted


name: Urinalysis other formed elements panel:Naric:Pt:Urine:Qn:Computer assisted


name: Oval fat bodies (globules):Naric:Pt:Urine:Qn:Computer assisted


name: Borrelia burgdorferi 49736 Ab.IgA:ACnc:Pt:Ser:Qn


name: Borrelia burgdorferi 49736 Ab.IgG:ACnc:Pt:Ser:Qn


name: Borrelia burgdorferi 49736 Ab.IgM:ACnc:Pt:Ser:Qn


name: Colorado tick fever virus Ab:PrThr:Pt:XXX:Ord


name: Herpes simplex virus Ab.IgG:Titr:Pt:Ser:SemiQn


name: Blood group antibody screen.cells I+II+III


name: Second trimester triple maternal screen panel


name: Surgical operation note open closing duration


name: Views PA + lateral + AP lateral-decubitus


name: Views PA + lateral + AP L-lateral-decubitus


name: Views PA + lateral + AP R-lateral-decubitus


name: 0.90% sodium chloride 24 hour 37 degree C incubation


name: after addition of 1:4 normal plasma 1 hour post incubation separate tubes


name: after addition of protein C activator+factor V depleted plasma


name: immediately after 4:1 addition of normal plasma


name: Continuity Assessment Record and Evaluation (CARE) set


name: Continuity Assessment Record and Evaluation (CARE) survey


name: Sjogrens syndrome-A extractable nuclear 52kD


name: Sjogrens syndrome-A extractable nuclear 60kD


name: Nucleic acid amplification detection limit = 0.5 log copies/mL


name: Views AP (R-lateral-decubitus & L-lateral-decubitus)


name: mandibular resection prosthesis (treatment)


name: urine urea nitrogen clearance (lab test)


name: Continuity Assessment Record and Evaluation


name: Forearm DXA scan Z score (assessment scale)


name: Forearm DXA scan T score (assessment scale)


name: Lumbar spine DXA scan Z score (procedure)


name: Lumbar spine DXA scan T score (procedure)


name: Quantitative ultrasound scan of heel - T score (procedure)


name: Quantitative ultrasound scan of heel - Z score (procedure)


name: Peritoneal Dialysis Fluid (body substance)


name: injection of eustachian tube with Teflon paste


name: examination of vermilion border of lower lip